Pfizer and Moderna Vaccines: Risk of Rare Cardiitis Included in US Prescribing

According to a local alert Friday, several cases of myocarditis or pericarditis have occurred in the United States after vaccinations, especially after the second dose. By the end of the second week of June, more than 1,200 such cases had been reported, mostly among men.

The FDA said inflammation was added to the list of potential risks after the CDC’s medical advisory team found, after several months of investigation, on Wednesday that there was a “potential link” between rare heart diseases in teens and young adults. adults; Between vaccinations with the Pfizer/BioNTech vaccine and the Moderna coronavirus vaccine.

In the first half of June, the Israeli Ministry of Health reported a possible link between heart infections and Pfizer vaccination.

Pharmaceutical company Pfizer, whose vaccine is officially approved to vaccinate Americans over the age of 12, previously said it had not seen a higher-than-expected rate of carditis.

Earlier, Moderna also reported that it had not found a causal relationship between cases of carditis and the use of the vaccine.

To date, more than 138 million Americans have been vaccinated twice with one of two mRNA-based vaccines, according to the CDC.

That huge number, and the result of 1,200 people above, is a rare risk among those vaccinated with the mRNA vaccine.

Cover image source: MTI / Bruzák Noémi. Pfizer-BioNTech’s coronavirus vaccine is being prepared for a second dose of Sunlight Home’s Premium Utility Corporation VIII. The nursing home on February 6, 2020.